Mirae Asset Global Investments
IOVA icon

Mirae Asset Global Investments’s Iovance Biotherapeutics IOVA Stock Holding History

Mirae Asset Global Investments’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.1K Sell
19,969
-1,519
-7% -$5.77K ﹤0.01% 1278
2026
Q1 		$75.4K Buy
21,488
+2,198
+11% +$7.03K ﹤0.01% 1225
2025
Q4 		$52.7K Buy
19,290
+5,301
+38% +$12.3K ﹤0.01% 1386
2025
Q3 		$30.4K Buy
13,989
+1,089
+8% +$2.57K ﹤0.01% 1431
2025
Q2 		$22.2K Buy
12,900
+1,929
+18% +$4.8K ﹤0.01% 1385
2025
Q1 		$39.1K Buy
10,971
+815
+8% +$4.2K ﹤0.01% 1288
2024
Q4 		$74.8K Sell
10,156
-822
-7% -$7.62K ﹤0.01% 1197
2024
Q3 		$105K Buy
10,978
+2,624
+31% +$24.9K ﹤0.01% 1178
2024
Q2 		$66.9K Sell
8,354
-79,924
-91% -$856K ﹤0.01% 1192
2024
Q1 		$772K Sell
88,278
-54,668
-38% -$636K ﹤0.01% 1675
2023
Q4 		$1.16M Sell
142,946
-5,068
-3% -$26.5K ﹤0.01% 1535
2023
Q3 		$673K Buy
148,014
+12,852
+10% +$83.9K ﹤0.01% 1744
2023
Q2 		$952K Buy
135,162
+25,791
+24% +$185K ﹤0.01% 1594
2023
Q1 		$668K Buy
109,371
+43,037
+65% +$297K ﹤0.01% 1779
2022
Q4 		$424K Buy
66,334
+56
+0.1% +$437 ﹤0.01% 1978
2022
Q3 		$635K Buy
66,278
+19,139
+41% +$221K ﹤0.01% 1734
2022
Q2 		$520K Buy
+47,139
New +$618K ﹤0.01% 1730
2019
Q1 		– Sell
-91,506
Closed -$810K – 1334
2018
Q4 		$810K Buy
91,506
+38,083
+71% +$367K 0.01% 828
2018
Q3 		$601K Buy
+53,423
New +$758K ﹤0.01% 985

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mirae Asset Global Investments's IOVA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Iovance Biotherapeutics (IOVA) stake by 7.1% in Q2 2026, selling an estimated $5.77K and leaving 19,969 shares worth $83.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1278.

Mirae Asset Global Investments first reported a position in IOVA in Q3 2018 and has held it in 19 quarters since. The position peaked at $1.16M in Q4 2023. 109 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Mirae Asset Global Investments held 19,969 shares of Iovance Biotherapeutics worth $83.1K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,519 Iovance Biotherapeutics shares in Q2 2026, an estimated $5.77K.
  • Iovance Biotherapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1278 holding.
  • Mirae Asset Global Investments first reported a position in Iovance Biotherapeutics in Q3 2018 and has held it in 19 quarters since.
  • Mirae Asset Global Investments's Iovance Biotherapeutics position peaked at $1.16M in Q4 2023.
  • 109 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.